Quick answer
Kramer Laboratories Recalls Safetussin Max Strength Multi-Symptom Cough, Cold and Flu Blister Packs Due to Risk of Child Poisoning; Violation of Federal Regulation for Child Resistant Packaging is CPSC recall #25223, announced on April 10, 2025. The CPSC cites the following hazard: This recall involves Safetussin Max Strength Multi-Symptom Cough, Cold and Flu 24-count caplet blister packs. They are labeled with "Safetussin," "Multi-Symptom," "Cough, Cold & Flu" and "Safe for adults with High Blood Pressure, Diabetes." They were sold in a blue, orange and red cardboard box with the drug facts label on the back. The remedy is consumers should immediately secure the product out of the sight and reach of children and contact kramer laboratories for information on how to return or dispose of the product for a full refund. only the packaging is being recalled, not the medicine itself, but both should be disposed.. Affected brand: Kramer Laboratories, of Bridgewater, New Jersey (a subsidiary of Arcadia Consumer Healthcare.
This recall involves Safetussin Max Strength Multi-Symptom Cough, Cold and Flu 24-count caplet blister packs. They are labeled with "Safetussin," "Multi-Symptom," "Cough, Cold & Flu" and "Safe for adults with High Blood Pressure, Diabetes." They were sold in a blue, orange and red cardboard box with the drug facts label on the back.
Affected products
Safetussin Max Strength Multi-Symptom Cough, Cold and Flu tablets blister packs
Recalled brands
Kramer Laboratories, of Bridgewater, New Jersey (a subsidiary of Arcadia Consumer Healthcare
Remedy
Consumers should immediately secure the product out of the sight and reach of children and contact Kramer Laboratories for information on how to return or dispose of the product for a full refund. Only the packaging is being recalled, not the medicine itself, but both should be disposed.
Recall date
April 10, 2025
CPSC recall #25223 covers Kramer Laboratories Recalls Safetussin Max Strength Multi-Symptom Cough, Cold and Flu Blister Packs Due to Risk of Child Poisoning; Violation of Federal Regulation for Child Resistant Packaging, announced by the U.S. Consumer Product Safety Commission on April 10, 2025. The CPSC cites the following hazard: This recall involves Safetussin Max Strength Multi-Symptom Cough, Cold and Flu 24-count caplet blister packs. They are labeled with "Safetussin," "Multi-Symptom," "Cough, Cold & Flu" and "Safe for adults with High Blood Pressure, Diabetes." They were sold in a blue, orange and red cardboard box with the drug facts label on the back.
The CPSC remedy for recall #25223 is consumers should immediately secure the product out of the sight and reach of children and contact kramer laboratories for information on how to return or dispose of the product for a full refund. only the packaging is being recalled, not the medicine itself, but both should be disposed.. Consumers should stop using the product and follow the instructions in the official CPSC notice.
If you sell Kramer Laboratories Recalls Safetussin Max Strength Multi-Symptom Cough, Cold and Flu Blister Packs Due to Risk of Child Poisoning; Violation of Federal Regulation for Child Resistant Packaging on Shopify, stop selling the affected units immediately, notify customers who purchased them, and consider whether you have a Section 15(b) reporting obligation to the CPSC. RecallDocket helps Shopify merchants identify affected SKUs and prepare the required safety report.
The primary source is the official CPSC notice at https://www.cpsc.gov/Recalls/2025/Kramer-Laboratories-Recalls-Safetussin-Max-Strength-Multi-Symptom-Cough-Cold-and-Flu-Blister-Packs-Due-to-Risk-of-Child-Poisoning-Violation-of-Federal-Regulation-for-Child-Resistant-Packaging. RecallDocket links to it from this page.
Sell on Shopify? Stay ahead of every CPSC recall.
RecallDocket automatically checks your catalog against new CPSC recalls and alerts you the moment one of your products is affected.
Install RecallDocket — free